Feed: Slashdot
Feed Link: https://slashdot.org/
---

Title: GLP-1 Drug Use Surges 600% as 2% of Americans Take Weight-Loss
Medications

Link: https://science.slashdot.org/story/25/05/27/1...

An anonymous reader shares a report: More than 2% of Americans are taking the
blockbuster class of GLP-1 drugs for overweight or obesity, up nearly 600%
over six years, according to a report from FAIR Health given to Axios first.
The data from FAIR Health's repository of over 51 billion commercial
healthcare claim records shows the explosion in use of the drugs specifically
for weight loss -- roughly half of all users. In all, roughly 4% of Americans
were taking GLP-1 drugs in 2024 for either overweight, obesity or Type 2
diabetes (their original approved use). The data shows Novo Nordisk's Ozempic
is still by far the most commonly taken GLP-1, followed by Eli Lilly's
Mounjaro. The percentage of adults who were prescribed a GLP-1 drug but did
not have bariatric surgery increased from 2.5% in 2019 to 11.2% in 2024 while
the the percentage of adult patients who had bariatric surgery decreased
41.8%.

Read more of this story at Slashdot.

---
VRSS v2.1.180528